The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R/JAK2/STAT1 pathway-mediated

Zhuo Zeng1, Yingying Lan1, Lijuan Zhang1

  • 1Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.

Burns & Trauma
|November 29, 2023
PubMed
Abstract

Insights

YTHDF2 acts as an inflammation inhibitor in sepsis by reducing HMGB1 release. This mechanism involves suppressing the IL-6R/JAK2/STAT1 pathway, highlighting YTHDF2 as a potential therapeutic target for sepsis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Biochemistry

Background:

  • Sepsis is a severe complication in burn victims, characterized by a dysregulated inflammatory response.
  • YTH domain family 2 (YTHDF2), an m6A reader, is involved in eukaryotic cellular processes, but its role in sepsis remains unexplored.

Purpose of the Study:

  • To investigate the effects and underlying mechanisms of YTHDF2 in sepsis.
  • To determine if YTHDF2 can serve as a therapeutic target for sepsis.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot to assess protein and mRNA expression.
  • Enzyme-linked immunosorbent assays (ELISAs) to measure inflammatory cytokine levels.
  • RNA immunoprecipitation and dual-luciferase reporter assays to confirm YTHDF2 targeting of IL-6R mRNA.
  • A mouse model of lipopolysaccharide (LPS)-induced sepsis to validate findings in vivo.

Main Results:

  • YTHDF2 expression was found to be low in septic conditions (mice, patients, and LPS-induced cells).
  • Overexpression of YTHDF2 reduced inflammation by inhibiting HMGB1 release and the JAK2/STAT1 signaling pathway in LPS-stimulated cells.
  • YTHDF2 suppresses IL-6R mRNA stability, thereby inhibiting HMGB1 release and the IL-6R/JAK2/STAT1 axis, demonstrating a protective role in septic mice.

Conclusions:

  • YTHDF2 acts as a crucial inhibitor of inflammation in sepsis.
  • YTHDF2 reduces HMGB1 release by modulating the IL-6R/JAK2/STAT1 pathway.
  • YTHDF2 represents a novel therapeutic target for sepsis interventions.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K